University of Michigan Office of Technology Transfer

Submit a New Inquiry

Technology #6084 - Combined use of IKK inhibitors with β-adrenergic receptor agonists for the treatment of obesity and metabolic disorders

University of Michigan Office of Technology Transfer contracts with Nouvant to provide this service.

Your inquiry will be sent to this technology's managers. All fields are required unless otherwise noted.

Optional

Optional

By submitting this inquiry you accept the terms of the Privacy Policy and Terms of Service.

Powered by Nouvant